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Abstract  
 
Objective: To assess the association between socioeconomic status (SES) and inflammatory markers using two different 
European population samples.  
Methods: We used data from the CoLaus (N=6412, Lausanne, Switzerland) and EPIPorto (N=1205, Porto, Portugal) 
studies. Education and occupational position were used as indicators of socioeconomic status (SES). High-sensitivity C-
Reactive Protein (hs-CRP) was available for both cohorts. Interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α) 
were available in CoLaus; leukocyte count and fibrinogen in EPIPorto.  
Results: We showed that low SES was significantly associated with high inflammation in both studies. We also showed 
that behavioural factors contributed the most to SES differences in inflammation. In both studies the larger difference 
between the lowest and the highest SES was observed for hs-CRP. In the Swiss sample, a linear association between 
education and hs-CRP persisted after adjustment for all mediating factors and confounders considered (p for linear trend 
<0.001).  
Conclusion: Large social differences exist in inflammatory activity, in part independently from demographic and 
behavioural factors, chronic conditions and medication use. SES differences in inflammation are also similar in 
countries with different underlying socioeconomic conditions. 
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Introduction 
 
Inflammation is a biological response of the immune system that is recognized as an important mechanism in the 
pathogenesis of atherosclerosis (Fahdi et al., 2003), as a risk factor for cardiovascular disease (Pearson et al., 2003; 
Willerson and Ridker, 2004), diabetes mellitus (Duncan et al., 2003; Pradhan et al., 2001), and cancer (Allin and 
Nordestgaard, 2011), and is also associated with increased mortality (Harris et al., 1999; Reuben et al., 2002). There is 
evidence to suggest that people exposed to social adversity have higher inflammatory status (Alley et al., 2006; Deverts 
et al., 2012; Jousilahti et al., 2003; Koster et al., 2006), i.e., high levels of C-reactive protein, serum amyloid A, 
fibrinogen, leukocyte count and cytokines. The impact of the social environment on inflammatory status can be 
explained by several processes. First, exposure to an adverse work environment elicits sustained stress reactions which 
impact inflammation; these exposures are likely to be experienced more frequently by socioeconomically disadvantaged 
groups (Siegrist and Marmot, 2004). Second, because of their increased vulnerability, individuals of lower 
socioeconomic status (SES) present a higher susceptibility to infections (Cohen, 1999; Cohen et al., 2004) and higher 
risk for chronic diseases (Galobardes et al., 2006b; Kaplan and Keil, 1993; Lawlor et al., 2003; Stringhini et al., 2012b). 
Although inflammation can be either a cause or a consequence of chronic diseases, in this study we consider chronic 
diseases as potential confounders of the SES-inflammation association. Finally, unhealthy behaviours such as smoking, 
heavy drinking, physical inactivity and BMI ≥ 30Kg/m2 might also account for the link between low SES and higher 
inflammatory status, as they are related to higher levels of inflammatory markers (Colbert et al., 2004; Frohlich et al., 
2003; Imhof et al., 2001) and are also more common among people with a low SES (Alley et al., 2006; Koster et al., 
2006; Stringhini et al., 2012a).  
 It is well established that low SES is related to higher levels of inflammation (Adler et al., 1993; Alley et al., 2006; 
Deverts et al., 2012; Hemingway et al., 2003; Koster et al., 2006; Stringhini et al., 2013). However, multicounty 
comparison is limited by the variety of SES indicators examined and the lack of harmonisation across studies. The study 
of this relationship in different settings can contribute to the understanding of the extent to which the environment in 
which people live influences the social patterning of inflammation. Thus, the present study aims to assess the 
association between SES and inflammatory markers using data from two population-based European cohorts with 
comparable design with regards to assessment of SES, health behaviours, chronic conditions and inflammatory markers: 
the CoLaus study (Lausanne, Switzerland, Central Europe) and the EPIPorto study (Porto, Portugal, South-western 
Europe). Given the large socioeconomic differences between Portugal and Switzerland, we hypothesize that the 
influence of SES on inflammation would be different in the two countries.  
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Participants and Methods 
 
Two European cohort studies provided data for our analyses: the CoLaus study (Lausanne, Switzerland) and the 
EPIPorto study (Porto, Portugal). 
 
The CoLaus study 
 
The CoLaus study was initiated in 2003 and recruited 6738 participants aged between 35 and 75 years in the city of 
Lausanne. More details on the CoLaus can be found elsewhere (Firmann et al., 2008; Marques-Vidal et al., 2011; 
Stringhini et al., 2012a). For the present analysis, we included data from the CoLaus wave 1 (2003-2006). From the 
initial 6738 CoLaus participants, exclusions were made because of missing information on education ((N=18) or 
because hs-CRP values were higher than 10mg/L (N=313). Hence, 6412 CoLaus participants (3351 women) were 
included in the present analysis. No significant differences were found between included and excluded participants for 
sociodemographic indicators and health behaviours. Analysis on occupational position was further restricted to 4586 
participants (1099 women), as information on occupational position was only available for those participants who were 
currently working. Excluded participants (i.e., non-working participants) were older (mean=61(SD=10.4) vs. mean=49 
(SD=8.8), p<0.001) and they were more likely to be women (OR=2.23; 95%CI: 1.99, 2.50), low educated (OR=2.18; 
95%CI: 1.94, 2.44), and obese (OR=1.66; 95%CI: 1.46, 1.89) and less likely to be smokers (OR=0.69; 95%CI:0.60, 
0.78).  
 
The EPIPorto study 
 
The EPIPorto study was initiated in 1999 and recruited 2485 adult dwellers aged 18 years or more in the city of Porto. 
More details about the recruitment can be found elsewhere (Pereira et al., 2012; Santos and Barros, 2003). For the 
present analysis we included data from the EPIPorto wave 2 (2005 -2008). Among the 1682 participants who 
participated in the EPIPorto wave 2 (68% of the baseline sample), 477 were not included in the present analysis (325 
because they were <35 or >75 years and thus not comparable with the CoLaus age range; 154 with hs-CRP levels > 10 
mg/L and 77 with leukocytes > 11×109/L). In the final analysis 1205 (772 women) participants were thus included. As 
in the CoLaus study, analysis on occupational position was further restricted to 1099 participants (677 women). No 
significant differences were found between included and excluded participants for sociodemographic indicators and 
health behaviours. 
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 Data collection 
 
In both studies, data were collected by trained interviewers through structured questionnaires and venous samples were 
drawn after an overnight fast.  
 
 
Socioeconomic Status 
 
Two commonly used indicators of SES were used: education and occupational position. In both studies, educational 
level was assessed as the highest qualification achieved and categorized as “high” (tertiary education), “medium” 
(upper secondary education) and “low” (lower secondary education or lower) (UNESCO, 2011). Participants’ 
occupational position was categorized as “high” (professional and managerial occupations), “medium” (non-manual and 
manual skilled occupations) and “low” (semi-skilled and unskilled occupations) (Galobardes et al., 2006a). 
 
Inflammatory Markers 
 
In the CoLaus study, high-sensitivity C-reactive protein (hs-CRP, mg/L) was assessed by immunoassay and latex HS 
(IMMULITE 1000-High, Diagnostic Products Corporation, Los Angeles, CA, USA). Interleukin-6 (IL-6) and tumour 
necrosis factor-α (TNF- α) levels were measured using a multiplexed particle-based flow cytometric cytokine assay 
(Vignali, 2000). 
 Milliplex kits were purchased from Millipore (Zug, Switzerland). The procedures closely followed the manufacturer’s 
instructions. The analysis was conducted using a conventional flow cytometer (FC500 MPL, BeckmanCoulter, Nyon, 
Switzerland). Values lower than the detection limit (0.2 pg/mL) were assigned a value equal to half the detection limit. 
(Hornung and Reed, 1990) This was done for 360 (8.4%) and 35 (0.8%) participants for IL-6 and TNF-α, respectively.  
In the EPIPorto study, hs-CRP was assessed through particle-enhanced immunonephelometry using a Behring auto-
analyser, Nephelometer II, BN II (Dade Behring Marburg GMBH, Germany). Total blood leukocyte count was used as 
(×109/L). Fibrinogen was assessed through coagulometry. 
Participants with hs-CRP levels higher than 10 mg/L in both studies and leukocytes > 11×109/L in EPIPorto were 
excluded from the analysis since these values were likely to represent an acute condition, and we intended to focus on 
chronic inflammation. 
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 Health Behaviours 
 
Current smoking was assessed using a questionnaire on current smoking status and was classified as yes/no. Former 
smokers were included in the non-smoker category. Alcohol consumption was self-reported and classified according to 
weekly consumption as abstainers (0 unit/week), moderate drinkers (1-21units/week for men and 1-14 units/week for 
women) or heavy drinkers (≥21/≥14 units/week for men/women). Participants were classified as physically active if 
they reported participating in a physical activity of more than 20 min once a week or more, and as physically inactive 
otherwise. Body weight and height were measured with participants standing without shoes in light indoor clothing. 
Body mass index (BMI) was calculated as weight (kg) divided by height squared (m2) (World Health Organization, 
2007). The standard deviation scores of BMI (BMI z-score) were also used in the present analysis. 
 
Chronic conditions and medication use 
 
Participants were asked about the presence of respiratory diseases, cancer, heart disease, diabetes, hypertension, 
inflammation-related conditions and depression. In both cohorts, current medication use was recorded and coded 
according to the Anatomic Therapeutic Chemical (ATC) classification system. For the present analysis, we considered 
only the regular use of anti-inflammatory products, non-steroids (MO1A) and corticosteroids for systemic use (H02). 
 
Demographics 
 
Demographics included gender, age and cohabitation. Living in couple was defined based on marital status 
(married/living common law vs. single or divorced or widow).  
 
 
 
Ethics Statement 
 
The CoLaus Study was approved by the Institutional Ethics Committee of the University of Lausanne (Switzerland) and 
the EPIPorto study was approved by the Ethic Committee of Porto Medical School Hospital São João (Portugal). In 
both studies, written informed consent was obtained from all participants. 
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 Statistical Analysis 
 
All analyses were performed using the statistical software SPSS version 21.0 (IBM, Armonk, USA). 
With the few exceptions mentioned below, all analyses were performed separately in the two cohorts. As no significant 
statistical interaction by gender in the association between SES and inflammatory markers was found (p for the 
interaction >0.05), data were analysed together for men and women. hs-CRP, leukocyte count, IL-6, TNF- α and 
fibrinogen were categorized in tertiles and then the prevalence of high hs-CRP, high leukocyte count, high IL-6, high 
TNF-α and high fibrinogen levels was presented based on the highest tertile vs. the two lower tertiles. The association 
of demographic factors, health behaviours and chronic conditions with inflammatory markers was assessed using 
logistic regression, and the results were expressed as Odds Ratio (OR) and 95% confidence interval (95%CI). 
The association between socioeconomic indicators (education and occupational position) and inflammatory markers 
was assessed using logistic regression and three models were used: adjusted for age and gender (model 1); adjusted for 
age, gender, marital status, current smoking, heavy drinking, inactivity, and BMI z-score (model 2) and adjusted for 
age, gender, marital status, current smoking, heavy drinking, inactivity, BMI z-score, chronic disease and anti-
inflammatory medication (model 3). For the present analyses we considered age, sex, marital status and underlying 
chronic conditions as confounders, and smoking, heavy drinking, inactivity and BMI as potential mediators, although a 
clear distinction between confounders and mediators is difficult to make in cross-sectional studies. 
Differences (and their 95% CI) in inflammation between the highest and the lowest educational/occupational group 
were calculated using linear regression. Variables with skewed distributions (hs-CRP, IL-6, TNF-α, Leukocyte and 
Fibrinogen) were log transformed for use in the linear regression models and the p-value for linear trend across 
socioeconomic categories was estimated.  
In order to test whether the association between SES and inflammatory markers differed by cohort, an interaction term 
between SES and cohort was fitted in the regression models including both cohorts. Statistical significance was 
considered for p<0.05.  
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Results 
 
Table 1 shows the distribution of participants across the educational and occupational categories in the two cohorts. In 
both cohorts, participants with a low SES were older (with the exception of those with a low occupational position in 
CoLaus who tended to be younger). Participants with a low educational level and occupational position had a higher 
proportion of current smoking, heavy drinking, inactivity, BMI ≥ 30Kg/m2, chronic disease and anti-inflammatory drug 
use. Contrary to CoLaus, EPIPorto participants of low SES had a lower proportion of current smoking. In both cohorts, 
participants with a lower educational level tended to present high levels of inflammatory markers. Similarly, 
participants with a low occupational position had higher hs-CRP and TNF-α (only assessed in the CoLaus study) levels 
and fibrinogen (only assessed in the EPIPorto study) compared to those with a higher occupational position. High 
leukocyte count was more frequent among participants with a middle occupational position. 
Table 2 shows the association between inflammatory markers and demographic, behavioural factors and chronic 
conditions in the two studies. Men were more likely to present high IL-6 (OR=1.24; 95%CI: 1.12, 1.38) and TNF-α 
(OR=1.26; 95%CI: 1.13, 1.40) comparing to women. However, men were more likely than women to present lower 
values of fibrinogen (OR=0.50; 95%CI: 0.37, 0.69), similarly to those living in couple instead of alone (OR=0.56; 
95%CI: 0.41, 0.76). In the two studies, current smoking, inactivity, BMI ≥ 30Kg/m2 and chronic conditions were 
positively associated with high levels of circulating inflammatory markers.  
Table 3 presents results for the association between inflammatory markers and education in the CoLaus and EPIPorto 
studies. The difference in the log of hs-CRP concentration between the lowest and the highest educational group was 
β=0.31; 95%CI=0.25, 0.37 in CoLaus and β=0.26; 95%CI=0.13, 0.40 in EPIPorto. When marital status and behavioural 
factors were added to the model, associations were reduced but remained statistically significant in the CoLaus cohort. 
Participants with a lower educational level had higher concentration of leukocytes and this association remained 
borderline significant (p=0.063) after adjustment for health behaviours. In the CoLaus study, significant associations 
were also found between IL-6 and education, but those more likely to have higher levels of IL-6 were participants with 
a  middle educational level (OR=1.40; 95%CI: 1.18, 1.65). TNF-α (measured in CoLaus) and fibrinogen (measured in 
EPIPorto) were not significantly patterned by education. When chronic conditions were added to model 2 (model 3), no 
significant changes were observed in the estimates. 
Associations between occupational position and inflammatory markers in the two cohorts are presented in Table 4. As 
for education, an inverse association was found between hs-CRP and occupational position in both cohorts, i.e., the 
odds of high hs-CRP increased with decreasing occupational position. Also, when marital status and behavioural factors 
were added to the age and sex adjusted model, the odds ratio was 1.30 (95%CI: 1.06, 1.60) in CoLaus and 1.13 (95%CI: 
8 
 
0.80, 1.60) in EPIPorto among those with low education comparing with high education. After adjustment for chronic 
conditions, the linear trend remained significant only in the CoLaus study (p<0.001). In CoLaus, after adjustment for 
health behaviours, no significant linear trend was observed for IL-6 and TNF-α. In EPIPorto, leukocytes were 
significantly associated with occupational position, with participants in the middle occupational category being more 
likely to have higher levels. Fibrinogen was not significantly associated with occupational position. When chronic 
conditions were added to model 2 (model 3), no significant reduction was observed in the difference of inflammatory 
markers between the lowest and the highest occupational position. 
We tested whether the association between SES and inflammatory markers differed in the two cohorts and no evidence 
was found for such an interaction (p for the interaction >0.05).  
 
Sensitivity Analyses 
 
We repeated the analysis for hs-CRP using the clinical threshold for high CRP (>3.0 mg/L). Results were similar to 
those presented using tertiles [see tables S1 and S2].  
Although analyses are adjusted for factors that we had hypothesized a priori as mediators or confounders of the SES-
inflammation association, we performed a Stepwise Logistic Regression in order to observe the factors most strongly 
altering the point estimates. Results showed that BMI and inactivity were the strongest mediators of the SES-
inflammation association [see Tables S3 and S4].   
Also, because categorizing chronic conditions as dichotomous variables might lead to loss of information, we have 
repeated the analysis on the SES distribution of chronic diseases separately for each disease [see Table S5]. Depression, 
hypertension and respiratory diseases were the most prevalent conditions in both countries and their prevalence was 
higher among low SES individuals. 
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Discussion   
 
SES and Inflammatory markers 
 
Among adults from two European population based-studies, low SES was associated with higher levels of inflammation 
as measured through hs-CRP, interleukin-6, TNF-α, leukocyte count and fibrinogen. These results are consistent with 
previous studies reporting associations between SES and chronic inflammation. (Koster et al., 2006; Loucks et al., 
2006; Stringhini et al., 2013) In both cohorts, the most consistent association was found for hs-CRP. CRP levels 
increased with lower education and with lower occupational position. However, in the CoLaus study the association of 
SES with hs-CRP seemed to be stronger, and persisted after adjustment for marital status and behavioural factors. We 
should note that the effect of SES on inflammation did not significantly differ by cohort. 
Similarly to hs-CRP, elevated blood leukocytes indicate an ongoing immune response, and a higher prevalence of 
chronic inflammatory conditions. After controlling for potential confounders/mediators, the association of leukocyte 
count with educational level and occupational position persisted in EPIPorto. Additionally, in the EPIPorto study, we 
observed that after adjustment for marital status and health behaviours the odds ratios for leukocyte count across 
education and occupational position increased. Because leukocyte and its components (particularly the granulocyte 
count) are strongly associated with cigarette smoking, (Smith et al., 2003) we may speculate that the observed increase 
in odds ratios is explained by higher smoking prevalence among higher SES individuals in EPIPorto.  
In EPIPorto, we observed an inverse association between SES and fibrinogen levels (lower SES individuals showing 
higher concentrations), although it did not persist after adjustment for confounders/mediators. An inverse association 
between SES and fibrinogen was reported in other studies (Jousilahti et al., 2003; Wilson et al., 1993).  
With regard to the association between SES and IL-6, results from previous studies were inconsistent. Most studies 
have found no significant associations between education, income or occupation and IL-6 (Brydon et al., 2004; Koster 
et al., 2006; Loucks et al., 2006). However, in another study employment grade was strongly inversely related to IL-6 
concentration after adjustment for age and sex (Hemingway et al., 2003). In the CoLaus study, we found a U-shaped 
association between SES and IL-6, with higher levels found in the middle educational and occupational group. 
Additionally, we observed a dose-response inverse association between occupational position and TNF-α. For both 
inflammatory markers, associations were explained away after adjustment for behavioural factors. 
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Role of demographic factors, behavioural factors and chronic conditions 
 
As a general pattern, behavioural factors seemed to explain a substantial part of SES differences in inflammatory 
marker levels. An unhealthy lifestyle, including smoking, heavy drinking, physical inactivity and BMI ≥ 30Kg/m2 is 
generally more prevalent in low vs. high SES groups and is also related to higher chronic inflammation. An exception is 
current smoking in Portugal, where people with a high vs. low SES are more likely to smoke (Cavelaars et al., 2000; 
Santos and Barros, 2004). Smoking has been significantly associated with increased inflammatory activity (Levitzky et 
al., 2008) and may be one of the mechanisms through which education influences inflammatory marker concentrations. 
Because of its different SES distribution in the two cohorts, in EPIPorto smoking is probably masking the effect of SES 
on inflammation while in CoLaus it is probably enhancing it. BMI ≥ 30Kg/m2 is also inversely related to SES and may 
be important to explain the association between SES and inflammation because IL-6 and TNF-α, for example, are 
produced within adipose tissue (Coppack, 2001). These markers are a primary stimulus for hs-CRP production in the 
liver and may trigger a cascade of inflammation (Coppack, 2001). Marital status was also considered a confounder 
although, with the exception of fibrinogen in EPIPorto, no association was found between marital status and 
inflammatory markers in this analysis. Although heavy drinking was generally positively associated with most 
inflammatory markers, it was negatively associated with fibrinogen levels in the Portuguese sample. This finding was 
reported in other studies (Galan et al., 2014; Sierksma et al., 2002) although the specific mechanisms or a plausible 
explanation remains uncertain. 
Additionally, chronic conditions may explain part of the association between SES and inflammation. People with low 
SES were more likely to present a chronic disease and they also had higher levels of inflammation. However, after 
controlling for chronic conditions, no significant changes were observed in the associations. 
In our study, we assessed two important indicators of SES such as education and occupational position in relation to 
several inflammatory markers in two European countries with different social and economic realities. It was not 
possible to examine the potential importance of individual income or financial strain for SES differences in 
inflammation, because this indicator was not available in any of the cohorts. However, other studies have shown that 
inflammatory markers were significantly negatively associated with income (Friedman and Herd, 2010). Additionally, 
other psychosocial factors may contribute to explain the association between SES and inflammation, for example social 
support. It is known that social support may contribute to buffer the impact of stressors (Taylor and Seeman, 1999). 
Therefore, psychosocial resources should be further explored as potential mediators in order to better understand the 
relationship between SES and chronic inflammation. 
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SES and country-specific characteristics 
 
Individual SES can also be a result of the social and economic context in which individuals live and grow. In the 
present study, we compared social differences in inflammation in two population samples from two European cities 
with different socioeconomic realities. Recent data from the Organization for Economic Co-operation and Development 
(OECD)(OECD, 2013) shows that the Swiss gross domestic product per capita was more than double than that of 
Portugal in 2012. Also, unemployment rate is higher in Portugal than in Switzerland (15.9% vs. 4.2%). Another 
important country indicator of a country’s degree of economic inequality is the Gini coefficient that represents the 
distribution of income in a population. The Gini coefficient in 2012 was 0.345 in Portugal and 0.288 in Switzerland, 
showing higher levels of inequality in Portugal. Despite the contextual differences between these two countries, we 
showed that the association of SES with inflammation is similar in a Portuguese and a Swiss city, suggesting that the 
context in which people has little impact on the social patterning of inflammation. 
 
Strengths and limitations 
 
The main strength of this study was the opportunity of using data from two different cohorts that have collected similar 
data allowing comparison between two different European settings. This study also has potential limitations. First, for 
analysis on occupational position we excluded participants that were not working and therefore not classifiable in their 
occupational position. In the Swiss cohort, almost 30% of the participants were excluded for analysis. Although it is not 
possible to know why these individuals were not working, given the higher proportion of women and elderly among the 
non-working participants we speculate that most were retired or non-working by their own option instead of 
unemployed. Second, in both studies, health behaviours were self-reported which may result in some misclassification 
of individual risk status. Third, it was not possible to have the same inflammatory markers in both cohorts (with the 
exception of hs-CRP) although available data confirmed the important role of socioeconomic status for these biological 
markers. Fourth, in our analysis we defined high values of inflammation based on the top tertile of each inflammatory 
marker, which is very dependent on the population distribution of the markers. However, most of the inflammatory 
markers, including those we use here, do not have defined clinical cutoffs that can be used instead of distribution-based 
cutoffs. 
 
Conclusions 
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Our results suggest that large social differences exist in inflammatory activity, and that these differences are similar 
using different indicators of SES and in different countries with different underlying socioeconomic conditions. Further 
research should explore the extent to which such differences in inflammatory activity contribute to explain, at least in 
part, social inequalities in inflammation-related diseases.   
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Table 1. Demographics, health behaviours, chronic conditions and inflammatory markers according to educational level 
and occupational position in the Swiss CoLaus and Portuguese EPIPorto studies.  
 
 Education (%)  Occupation (%) 
 High Medium Low  High Medium Low 
CoLaus 
 
n=1284 n=1555 n=3573  n=1832 n=1993 n=761 
Demographics        
Age, mean (SD) 49.6 (9.8) 51.9 (10.6) 53.7 (10.8) *  48.9 (8.8) 49.6 (8.8) 48.2 (8.5)** 
Male 57.2 45.3 45.4 *  62.4 48.8 43.3* 
Living in couple 56.9 58.7 60.6 ***  59.1 53.6 65.1* 
 
Health behaviours   
    
Current smoking 22.0 25.9 28.5 *  24.0 32.2 31.0 * 
Heavy drinking 8.1 7.8 8.4  8.2 9.0 8.7 
Inactivity  23.2 28.9 42.5 *  23.5 38.5 57.3 * 
BMI ≥ 30Kg/m2 10.2 15.9 23.7 *  12.3 19.0 21.7 * 
 
Chronic conditions    
    
Chronic disease 36.1 41.7 47.3 *  34.8 39.9 41.9 * 
Anti-inflammatory 
medication  2.1 4.3 5.8 * 
 2.1 4.1 3.8 * 
 
Inflammatory markers   
    
High hs-CRP 24.8 31.2 39.0 *  26.5 35.1 40.2* 
High IL-6 29.4 36.5 33.4 *  31.9 34.8 33.4 
High TNF-α 28.0 34.5 34.6 *  31.7 33.4    37.0 *** 
 
EPIPorto 
 
n=301 n=181 n=723 
 
n=421 n=329 n=349 
Demographics        
Age, mean (SD) 52.4 (9.8) 54.3 (10.6) 60.1 (9.9) *  54.4 (10.2) 57.9 (10.6) 59.6 (10.3)* 
Male 37.5 43.1 33.5 ***  43.0 43.5 28.1 * 
Living in couple 67.8 74.0 74.1  72.2 72.0 73.9 
 
Health behaviours 
      
Current smoking 28.2 17.1 14.2 *  24.5 18.9) 12.1 * 
Heavy drinking 10.0 22.3 25.2 *  15.1 26.6 23.7 * 
Physical inactivity  43.9 41.4 58.7 *  42.5 48.3 67.7 * 
BMI ≥ 30Kg/m2 16.3 26.7 38.4 *  18.8 30.6 43.0 * 
Chronic conditions    
    
Chronic disease 50.8 65.2 67.7 *  54.4 64.4 70.7 * 
Anti-inflammatory 
medication  4.3 6.1 12.3 * 
 5.2 9.7 13.2 ** 
 
Inflammatory markers 
      
High hs-CRP 22.9 22.7 29.2 ***  29.0 32.8 40.7 ** 
High leukocyte count 27.9 31.5 33.1  34.1 35.3 30.5 
High fibrinogen 26.0 29.6 30.3  31.4 34.1 34.8 
ANOVA or the Chi-square test *p<0.001, **p<0.01, ***p<0.05 
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Table 2. Non-adjusted OR (95%CI)) between inflammatory markers (highest tertile vs. lower tertiles) and demographic factors, behavioural factors and chronic conditions in the 
Swiss CoLaus and Portuguese EPIPorto studies. 
 
 CoLaus N=6412 
EPIPorto 
N=1205 
 
High hs-CRP 
OR (95%CI) 
High IL-6 
OR (95%CI) 
High TNF-α 
OR (95%CI) 
 High hs-CRP 
OR (95%CI) 
High leukocyte 
OR (95%CI) 
High Fibrinogen 
OR (95%CI) 
Demographics        
Gender (ref.: women) 0.82 (0.74, 0.91) 1.24 (1.12, 1.38) 1.26 (1.13, 1.40)  0.60 (0.45, 0.80) 1.33 (1.04, 1.71) 0.50 (0.37, 0.69) 
Age 1.03 (1.02, 1.03) 1.01 (1.00, 1.01) 1.02 (1.01, 1.02)  1.00 (0.99, 1.01) 0.98 (0.97, 1.00) 1.03 (1.01, 1.04) 
Living in couple (ref.:no) 0.95 (0.86, 1.06) 1.02 (0.91, 1,13) 1.03 (0.92, 1.15)  1.00 (0.75, 1.34) 1.18 (0.89, 1.55) 0.56 (0.41, 0.76) 
 
Health behaviours 
 
   
 
   
Current smoking (ref.:no) 1.19 (1.06, 1.33) 1.38 (1.22, 1.55) 1.14 (1.01, 1.29)  1.25 (0.90, 1.72) 4.05 (2.99, 5.50) 1.25 (0.86, 1.80) 
Heavy drinking (ref.:no) 1.22 (1.02, 1.47) 1.40 (1.16, 1.70) 1.23 (1.02, 1.49)  0.97 (0.71, 1.34) 0.81 (0.59, 1.10) 0.56 (0.39, 0.81) 
Physical Inactivity (ref.:no) 1.57 (1.41, 1.75) 1.22 (1.09, 1.70) 1.10 (0.98, 1.49)  1.58 (1.22, 2.04) 1.17 (0.84, 1.49) 1.23 (0.93, 1.63) 
BMI ≥ 30Kg/m2 (ref.: no) 3.76 (3.30, 4.28) 1.40 (1.23, 1.60) 1.55 (1.36, 1.77)  2.19 (1.68, 2.86) 1.31 (1.01, 1.69) 1.55 (1.16, 2.07) 
        
 
Chronic conditions 
 
   
 
   
Chronic disease (ref.:no) 1.84 (1.66, 2.04) 1.19 (1.07, 1.33) 1.25 (1.12, 1.39)  1.62 (1.23, 2.13) 1.43 (1.10, 1.85) 1.10 (0.82, 1.47) 
Anti-inflammatory medication (ref. :no) 1.51 (1.19, 1.91) 1.12 (0.88, 1.43) 1.27 (1.00, 1.62)  1.32 (0.87, 2.01) 1.02 (0.67, 1.54) 1.32 (0.85, 2.06) 
             High inflammatory marker corresponds to high tertile vs. lower tertiles 
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Table 3. Association between inflammatory markers and educational level in the Swiss CoLaus and 
Portuguese EPIPorto studies  
 
 Education    
 
 High ORa   
Medium 
ORa (95%CI) 
Low 
ORa (95%CI) ∆
b (95%CI) pc 
CoLaus 
N=6412 
 
      
hs-CRP 
Model 1 
Model 2 
Model 3 
 
1.00 
1.00 
1.00 
 
1.27 (1.08, 1.51) 
1.09 (0.91, 1.30) 
1.09 (0.91, 1.30) 
 
1.72 (1.49, 1.99) 
1.20 (1.02, 1.40) 
1.20 (1.02, 1.40) 
 
0.31 
0.11  
0.11 
 
0.25, 0.37 
0.05, 0.16 
0.05, 0.16 
 
<0.001 
<0.001 
<0.001 
IL-6 
Model 1 
Model 2 
Model 3 
 
1.00 
1.00 
1.00 
 
1.40 (1.18, 1.65) 
1.31 (1.10, 1.55) 
1.30 (1.10, 1.54) 
 
1.21 (1.04, 1.40) 
1.06 (0.91, 1.23) 
1.05 (0.91, 1.23) 
 
0.10 
0.01 
0.01 
 
0.01, 0.21 
-0.11, 0.11 
-0.11, 0.11 
 
0.050 
0.998 
0.999 
TNF-α 
Model 1 
Model 2 
Model 3 
 
1.00 
1.00 
1.00 
 
1.34 (1.13, 1.59) 
1.28 (1.08, 1.52) 
1.28 (1.08, 1.52) 
 
1.30 (1.12, 1.51) 
1.18 (1.01, 1.38) 
1.18 (1.01, 1.38) 
 
0.07 
0.03 
0.03 
 
0.01, 0.13 
-0.03, 0.09 
-0.03, 0.09 
 
0.030 
0.374 
0.350 
 
EPIPorto 
N=1205 
 
      
hs-CRP 
Model 1 
Model 2 
Model 3 
 
1.00 
1.00 
1.00 
 
1.03 (0.66, 1.60) 
0.92 (0.56, 1.52) 
0.89 (0.54, 1.46) 
 
1.42 (1.02, 1.98) 
1.25 (0.85, 1.83) 
1.21 (0.82, 1.78) 
 
0.26 
0.11 
0.10 
 
0.13, 0.40 
-0.03, 0.25 
-0.04, 0.24 
 
<0.001 
0.130 
0.168 
Leukocyte 
Model 1 
Model 2 
Model 3 
 
1.00 
1.00 
1.00 
 
1.26 (0.84, 1.89) 
1.43 (0.90, 2.27) 
1.35 (0.84, 2.15) 
 
1.53 (1.12, 2.09) 
1.68 (1.16, 2.44) 
1.64 (1.13, 2.38) 
 
0.04 
0.03 
0.03 
 
0.01, 0.08 
-0.002, 0.07 
-0.003, 0.07 
 
0.014 
0.063 
0.071 
Fibrinogen 
Model 1 
Model 2 
Model 3 
 
1.00 
1.00 
1.00 
 
1.10 (0.68, 1.78) 
0.99 (0.59, 1.67) 
1.02 (0.60, 1.72) 
 
0.95 (0.65, 1.39) 
0.98 (0.65, 1.49) 
1.00 (0.66, 1.53) 
 
-0.004 
0.004 
0.005 
 
-0.04, 0.03 
-0.03, 0.04 
-0.03, 0.04 
 
0.818 
0.839 
0.807 
a Odds Ratios (ORs) and 95% Confidence Intervals (95%CIs) were calculated through a Logistic 
Regression 
Model 1= adjusted for age and gender 
Model 2= adjusted for age, gender, living in couple, current smoking, heavy drinking, inactivity and BMI 
z-score 
Model 3= adjusted for age, gender, living in couple, current smoking, heavy drinking, inactivity,  BMI z-
score, chronic disease and anti-inflammatory medication 
b Difference (∆) and 95% Confidence Intervals (95%CIs)  in inflammatory marker concentration on the 
log scale between the highest and the lowest educational category were calculated through Linear 
Regression 
c p-value for linear trend across education categories 
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Table 4. Association between inflammatory markers and occupational position in the Swiss CoLaus and 
Portuguese EPIPorto studies. 
 
 
 Occupation    
 
 High 
ORa 
Medium 
ORa (95%CI) 
Low 
ORa (95%CI) 
 
∆b 
 
(95%CI) 
 
pc 
 
CoLaus 
N=4586 
 
      
hs-CRP 
Model 1 
Model 2 
Model 3 
 
1.00 
1.00 
1.00 
 
1.48 (1.29, 1.71) 
1.16 (1.00, 1.36) 
1.17 (1.00, 1.36) 
 
1.92 (1.60, 2.30) 
1.30 (1.06, 1.60) 
1.30 (1.06, 1.60) 
 
0.38 
0.16 
0.16 
 
0.30, 0.46 
0.09, 0.24 
0.09, 0.24 
 
<0.001 
<0.001 
<0.001 
IL-6 
Model 1 
Model 2 
Model 3 
 
1.00 
1.00 
1.00 
 
1.16 (1.01, 1.33) 
1.06 (0.92, 1.23) 
1.07 (0.92, 1.24) 
 
1.12 (0.93, 1.36) 
1.02 (0.83, 1.24) 
1.02 (0.83, 1.25) 
 
0.23 
0.12 
0.12 
 
0.09, 0.37 
-0.03, 0.26 
-0.02, 0.27 
 
0.002 
0.117 
0.097 
TNF-α 
Model 1 
Model 2 
Model 3 
 
1.00 
1.00 
1.00 
 
1.11 (0.96, 1.28) 
1.03 (0.89, 1.19) 
1.03 (0.89, 1.20) 
 
1.36 (1.13, 1.64) 
1.25 (1.02, 1.49) 
1.25 (1.02, 1.53) 
 
0.09 
0.05 
0.05 
 
0.01, 0.18 
-0.03, 0.13 
-0.03, 0.14 
 
0.021 
0.249 
0.195 
 
EPIPorto 
N=1099 
 
      
hs-CRP 
Model 1 
Model 2 
Model 3 
 
1.00 
1.00 
1.00 
 
1.16 (0.85, 1.59) 
0.99 (0.71, 1.39) 
0.98 (0.70, 1.37) 
 
1.51 (1.11, 2.06) 
1.13 (0.80, 1.60) 
1.11 (0.79, 1.57) 
 
0.32 
0.12 
0.11 
 
0.17, 0.46 
-0.02, 0.26 
-0.03, 0.25 
 
<0.001 
0.104 
0.138 
Leukocyte 
Model 1 
Model 2 
Model 3 
 
1.00 
1.00 
1.00 
 
1.61 (1.18, 2.20) 
1.75 (1.24, 2.46) 
1.71 (1.21, 2.42) 
 
1.49 (1.09, 2.05) 
1.57 (1.10, 2.25) 
1.54 (1.07, 2.21) 
 
0.05 
0.03 
0.03 
 
0.01, 0.08 
-0.003, 0.07 
-0.004,0.07 
 
0.009 
0.072 
0.082 
Fibrinogen 
Model 1 
Model 2 
Model 3 
 
1.00 
1.00 
1.00 
 
1.00 (0.70, 1.43) 
0.99 (0.68, 1.43) 
1.00 (0.69, 1.45) 
 
0.88 (0.61, 1.27) 
0.87 (0.58, 1.28) 
0.89 (0.60, 1.32) 
 
-0.014 
-0.013 
-0.013 
 
-0.05, 0.02 
-0.05, 0.02 
-0.05, 0.02 
 
0.459 
0.498 
0.519 
a Odds Ratios (ORs) and 95% Confidence Intervals (95%CIs) were calculated through a Logistic 
Regression 
Model 1= adjusted for age and gender 
Model 2= adjusted for age, gender, living in couple, current smoking, heavy drinking, inactivity and BMI 
z-score 
Model 3= adjusted for age, gender, living in couple, current smoking, heavy drinking, inactivity, BMI z-
score, chronic disease and anti-inflammatory medication 
b Difference (∆) and 95% Confidence Intervals (95%CIs)  in inflammatory marker concentration on the 
log scale between the highest and the lowest occupational category were calculated through Linear 
Regression 
c p-value for linear trend across occupational categories 
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Supplementary tables: 
 
Table S1. Non-adjusted OR (95%CI) for the association between high-sensitivity C-reactive protein 
(high CRP defined as CRP>3mg/L) and demographic and behavioural factors and chronic conditions in 
the Swiss CoLaus and the Portuguese EPIPorto studies. 
 
 
 CoLaus N=6412 
EPIPorto 
N=1205 
 OR (95%CI) OR (95%CI) 
Demographics   
Gender (ref.: women) 0.82 (0.72, 0.93) 0.67 (0.51, 0.88) 
Age 1.02 (1.01, 1.02) 1.01 (1.00, 1.02) 
Living in couple (ref.:no) 0.89 (0.78, 1.02) 0.97 (0.73, 1.28) 
   
Health behaviours   
Current smoking (ref.:no) 1.11 (0.96, 1.27) 1.22 (0.89, 1.67) 
Heavy drinking (ref.:no) 1.20 (0.96, 1.51) 1.08 (0.80, 1.47) 
Physical Inactivity (ref.:no) 1.56 (1.37, 1.78) 1.52 (1.18, 1.96) 
BMI ≥ 30Kg/m2 (ref.: no) 3.39 (2.94, 3.90) 2.21 (1.63, 2.75) 
   
Chronic conditions   
Chronic disease (ref.:no) 1.82 (1.60, 2.07) 1.57 (1.20, 2.06) 
Anti-inflammatory medication (ref. :no) 1.47 (1.12, 1.94) 1.21 (0.80, 1.82) 
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Table S2. Association between high-sensitivity C-reactive protein (high CRP defined as CRP>3mg/L) 
and educational level and occupational position in the Swiss CoLaus and the Portuguese EPIPorto studies  
 
 Education  Occupation  
 High Medium Low  High Medium Low 
CoLaus 
 n=1284 n=1555 n=3573  n=1832 n=1993 n=761 
hs-CRP>3mg/L 12.4% 17.5% 20.9% *  12.6% 18.4% 21.6% * 
OR (95%CI)        
Model 0 1.00 1.50 (1.21, 1.85) 1.86 (1.55, 2.25)  1.00 1.56 (1.30, 1.87) 1.90 (1.52, 2.38) 
Model 1 1.00 1.42 (1.15, 1.77) 1.73 (1.43, 2.10)  1.00 1.53 (1.27, 1.84) 1.90 (1.52, 2.39) 
Model 2 1.00 1.24 (1.00, 1.56) 1.22 (1.00, 1.50)  1.00 1.52 (1.27, 1.83) 1.94 (1.54, 2.43) 
Model 3 1.00 1.24 (0.99, 1.55) 1.22 (1.00, 1.49)  1.00 1.21 (1.00, 1.47) 1.38 (1.08, 1,77) 
        
EPIPorto 
 n=301 n=181 n=723  n=421 n=329 n=349 
hs-CRP>3mg/L 24.5% 23.8% 32.4% **  23.3% 27.5% 35.0% ** 
OR (95%CI)        
Model 0 1.00 0.96 (0.62, 1.48) 1.48 (1.09, 2.01)  1.00 1.25 (0.90, 1.75) 1.77 (1.29, 2.43) 
Model 1 1.00 0.98 (0.63, 1.52) 1.46 (1.05, 2.01)  1.00 1.25 (0.89, 1.74) 1.67 (1.20, 2.31) 
Model 2 1.00 0.88 (0.54, 1.43) 1.26 (0.87, 1.83)  1.00 1.10 (0.77, 1.58) 1.32 (0.92, 1.89) 
Model 3 1.00 0.85 (0.52, 1.38) 1.24 (0.85, 1.80)  1.00 1.09 (0.76, 1.56) 1.30 (0.90, 1.87) 
Model 0=non-adjusted 
Model 1= adjusted for age and gender 
Model 2= adjusted for age, gender, living in couple, current smoking, heavy drinking, inactivity and BMI 
z-score 
Model 3= adjusted for age, gender, living in couple, current smoking, heavy drinking, inactivity,  BMI z-
score, chronic disease and anti-inflammatory medication 
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Table S3. Stepwise logistic regression between inflammatory markers and educational level and occupational 
position in the Swiss CoLaus  
 
 
CoLaus 
 
Education 
N=6412 
 Occupation 
N=4586 
 
 High OR 
Medium 
OR (95%CI) 
Low 
OR (95%CI) 
High 
OR 
Medium 
OR (95%CI) 
Low 
OR (95%CI) 
hs-CRP 
Crude 
Sex+age 
+living couple 
+Smoking 
+Drinking 
+Inactivity 
+zBMI 
 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
 
1.37 (1.16, 1.62) 
1.27 (1.08, 1.51) 
1.27 (1.08, 1.51) 
1.26 (1.06, 1.49) 
1.23 (1.04, 1.46) 
1.22 (1.03, 1.45) 
1.09 (0.91, 1.30) 
 
1.93 (1.67, 2.23) 
1.72 (1.49, 1.99) 
1.72 (1.49, 1.99) 
1.69 (1.46, 1.96) 
1.66 (1.43, 1.92) 
1.55 (1.33, 1.80) 
1.20 (1.02, 1.40) 
 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
 
1.50 (1.30, 172) 
1.48 (1.29, 1.71) 
1.48 (1.28, 1.70) 
1.44 (1.25, 1.66) 
1.42 (1.23, 1.63) 
1.32 (1.14, 1.53) 
1.16 (1.00, 1.36) 
 
1.86 (1.56, 2.22) 
1.92 (1.60, 2.30) 
1.94 81.62, 2.33) 
1.90 (1.58, 2.28) 
1.88 (1.57, 2.26) 
1.63 (1.35, 1.98) 
1.30 (1.06, 1.60) 
CRP>3.0mg/L 
Crude 
Sex+age 
+living couple 
+Smoking 
+Drinking 
+Inactivity 
+zBMI 
 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
 
1.50 (1.21, 1.85) 
1.42 (1.15, 1.77) 
1.43 (1.15, 1.77) 
1.42 (1.14, 1.76) 
1.41 (1.14, 1.75) 
1.40 (1.12, 1.74) 
1.24 (1.00, 1.56) 
 
1.86 (1.55, 2.25) 
1.73 (1.43, 2.10) 
1.74 (1.44, 2.11) 
1.73 (1.43, 2.09) 
1.68 (1.39, 2.04) 
1.58 (1.30, 1.93) 
1.22 (1.00, 1.50) 
 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
 
1.56 (1.30, 1.87) 
1.53 (1.27, 1.84) 
1.52 (1.27, 1.83) 
1.50 (1.25, 1.81) 
1.47 (1.22, 1.76) 
1.37 (1.14, 1.65) 
1.21 (1.00, 1.47) 
 
1.91 (1.53, 2.39) 
1.91 (1.52, 2.39) 
1.94 (1.55, 2.43) 
1.92 (1.53, 2.41) 
1.92 (1.53, 2.41) 
1.70 (1.34, 2.16) 
1.38 (1.08, 1.77) 
IL-6 
Crude 
Sex+age 
+living couple 
+Smoking 
+Drinking 
+Inactivity 
+zBMI 
 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
 
1.38 (1.17, 1.62) 
1.40 (1.18, 1.65) 
1.40 (1.19, 1.65) 
1.37 (1.16, 1.62) 
1.35 (1.14, 1.59) 
1.34 (1.13, 1.59) 
1.31 (1.10, 1.55) 
 
1.20 (1.04, 1.39) 
1.21 (1.04, 1.40) 
1.21 (1.04, 1.40) 
1.17 (1.01, 1.36) 
1.16 (1.00, 1.34) 
1.12 (0.97, 1.31) 
1.06 (0.91, 1.23) 
 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
 
1.14 (1.00, 1.31) 
1.16 (1.01, 1.33) 
1.16 (1.01, 1.33) 
1.13 (0.98, 1.30) 
1.13 (0.98, 1.30) 
1.10 (0.95, 1.27) 
1.06 (0.92, 1.23) 
 
1.07 (0.89, 1.29) 
1.12 (0.93, 1.36) 
1.12 (0.93, 136) 
1.09 (0.90, 1.32) 
1.09 (0.90, 1.32) 
1.07 (0.88, 1.31) 
1.02 (0.83, 1.24) 
TNF-α 
Crude 
Sex+age 
+living couple 
+Smoking 
+Drinking 
+Inactivity 
+zBMI 
 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
 
1.35 (1.15, 1.60) 
1.34 (1.13, 1.59) 
1.34 (1.13, 1.59) 
1.33 (1.12, 1.57) 
1.32 (1.11, 1.57) 
1.32 (1.11, 1.57) 
1.28 (1.08, 1.52) 
 
1.36 (1.18, 1.57) 
1.30 (1.12, 1.51) 
1.30 (1.12, 151) 
1.28 (1.11, 1.49) 
1.27 (1.09, 1.48) 
1.27 (1.09, 1.48) 
1.18 (1.01, 1.38) 
 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
 
1.08 (0.94, 1.25) 
1.11 (0.96, 1.28) 
1.11 (0.96, 1.28) 
1.09 (0.95, 1.26) 
1.08 (0.94, 1.25) 
1.08 (0.93, 1.25) 
1.03 (0.90, 1.19) 
 
1.27 (1.05, 1.52) 
1.36 (1.13, 1.64) 
1.36 (1.13, 1.64) 
1.34 (1.11, 1.62) 
1.34 (1.11, 1.62) 
1.35 (1.11, 1.65) 
1.25 (1.02, 1.53) 
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Table S4. Stepwise logistic regression between inflammatory markers and educational level and occupational 
position in the Portuguese EPIPorto 
 
 
 
EPIPorto 
 
Education 
N=1205 
Occupation  
N=1099 
 
High 
OR 
Medium 
OR (95%CI) 
Low 
OR (95%CI) 
High 
OR 
Medium 
OR (95%CI) 
Low 
OR (95%CI) 
hs-CRP 
Crude 
Sex+age 
+living couple 
+Smoking 
+Drinking 
+Inactivity 
+zBMI 
 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
 
0.98 (0.63, 1.53) 
1.03 (0.66, 1.60) 
1.02 (0.65, 1.59) 
1.05 (0.67, 1.65) 
1.08 (0.68, 1.71) 
1.07 (0.68, 1.70) 
0.92 (0.56, 1.52) 
 
1.39 (1.01, 1.89) 
1.42 (1.02, 1.98) 
1.40 (1.01, 1.95) 
1.45 (1.03, 2.02) 
1.50 (1.06, 2.13) 
1.41 (0.99, 2.01) 
1.25 (0.85, 1.83) 
 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
 
1.20 (0.88, 1.64) 
1.16 (0.85, 1.59) 
1.16 (0.85, 1.59) 
1.18 (0.86, 1.62) 
1.16 (0.84, 1.61) 
1.14 (0.82, 1.58) 
0.99 (0.71, 1.39) 
 
1.68 (1.25, 2.27) 
1.51 (1.11, 2.06) 
1.51 (1.11, 2.06) 
1.55 (1.13, 2.12) 
1.52 (1.10, 2.09) 
1.40 (1.01, 1.95) 
1.13 (0.80, 1.60) 
CRP>3.0mg/L 
Crude 
Sex+age 
+living couple 
+Smoking 
+Drinking 
+Inactivity 
+zBMI 
 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
 
0.96 (0.62, 1.48) 
0.98 (0.63, 1.52) 
0.98 (0.63, 1.51) 
1.01 (0.65, 1.56) 
1.02 (0.65, 1.60) 
1.02 (0.65, 1.60) 
0.88 (0.54, 1.43) 
 
1.48 (1.09, 2.01) 
1.46 (1.05, 2.01) 
1.45 (1.04, 2.01) 
1.49 (1.07, 2.07) 
1.51 (1.08, 2.13) 
1.43 (1.01, 2.02) 
1.26 (0.87, 1.83) 
 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
 
1.25 (0.90, 1.75) 
1.25 (0.89, 1.74) 
1.24 (0.89, 1.74) 
1.27 (0.90, 1.78) 
1.28 (0.91, 1.82) 
1.26 (0.89, 1.79) 
1.10 (0.77, 1.58) 
 
1.77 (1.29, 2.43) 
1.67 (1.20, 2.31) 
1.66 (1.20, 2.31) 
1.71 (1.23, 2.38) 
1.72 (1.23, 2.42) 
1.62 (1.15, 2.30) 
1.32 (0.92, 1.89) 
Leukocyte 
Crude 
Sex+age 
+living couple 
+Smoking 
+Drinking 
+Inactivity 
+zBMI 
 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
 
1.19 (0.79, 1.78) 
1.26 (0.84, 1.89) 
1.26 (0.84, 1.89) 
1.48 (0.96, 2.27) 
1.55 (1.00, 2.42) 
1.55 (1.00, 2.42) 
1.43 (0.90, 2.27) 
 
1.28 (0.95, 1.71) 
1.53 (1.12, 2.09) 
1.52 (1.11, 2.09) 
1.73 (1.24, 2.42) 
1.89 (1.33, 2.68) 
1.85 (1.30, 2.63) 
1.68 (1.16, 2.44) 
 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
 
1.52 (1.12, 2.06) 
1.61 (1.18, 2.20) 
1.61 (1.18, 2.20) 
1.73 (1.24, 2.40) 
1.86 (1.33, 2.61) 
1.86 (1.32, 2.61) 
1.75 (1.24, 2.46) 
 
1.31 (0.97, 1.78) 
1.49 (1.09, 2.05) 
1.49 (1.08, 2.05) 
1.69 (1.21, 2.35) 
1.78 (1.26, 2.51) 
1.78 (1.25, 2.53) 
1.57 (1.10, 2.25) 
Fibrinogen 
Crude 
Sex+age 
+living couple 
+Smoking 
+Drinking 
+Inactivity 
+zBMI 
 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
 
1.19 (0.74, 1.91) 
1.10 (0.68, 1.78) 
1.14 (0.70, 1.85) 
1.19 (0.73, 1.94) 
1.15 (0.70, 1.89) 
1.15 (0.70, 1.88) 
0.99 (0.59, 1.67) 
 
1.23 (0.87, 1.75) 
0.95 (0.65, 1.39) 
0.99 (0.68, 1.45) 
1.04 (0.70, 1.52) 
1.03 (0.69, 1.52) 
0.98 (0.66, 1.46) 
0.98 (0.65, 1.49) 
 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
 
1.13 (0.80, 1.60) 
1.00 (0.70, 1.43) 
1.01 (0.70, 1.44) 
1.02 (0.71, 1.46) 
1.04 (0.72, 1.50) 
1.02 (0.71, 1.48) 
0.99 (0.68, 1.43) 
 
1.16 (0.82, 1.64) 
0.88 (0.61, 1.27) 
0.91 (0.63, 1.31) 
0.93 (0.64, 1.35) 
0.96 (0.66, 1.41) 
0.92 (0.62, 1.35) 
0.87 (0.58, 1.28) 
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Table S5. Chronic conditions according to educational and occupational position in the Swiss CoLaus and the 
Portuguese EPIPorto studies.  
 
 Education (%)  Occupation (%) 
 High Medium Low  High Medium Low 
CoLaus 
 
n=1284 n=1555 n=3573  n=1832 n=1993 n=761 
Depression 13.1 16.3 18.4 *  11.6 16.9 18.8 * 
Diabetes 2.4 3.7 5.1 *  3.1 3.5 3.3 
Hypertension 12.4 17.7 22.8 *  13.5 16.0 18.3 ** 
Heart disease 1.6 3.0 4.3 *  1.5 2.8 2.6 *** 
Cancer 2.1 2.8 3.0  1.4 1.7 1.6 
Respiratory diseases 12.1 11.3 12.0  11.7 10.6 10.8 
Inflammation-related 
conditions 1.9 2.8 3.0 
 1.8 2.6 1.7 
        
 
EPIPorto 
 
n=301 n=181 n=723 
 
n=421 n=329 n=349 
Depression 27.9 31.5 35.3   25.9 37.1 35.9 ** 
Diabetes 3.7 8.3 11.4 *  5.0 8.8 12.8 * 
Hypertension 23.3 34.8 39.0 *  26.4 32.8 42.9 * 
Heart disease 3.7 6.1 6.5  4.3 6.4 7.2 
Cancer 5.0 6.6 5.3  6.2 5.2 4.3 
Respiratory diseases  8.0 6.1 12.9 **  8.1 9.1 14.4 *** 
Inflammation-related 
conditions 7.3 10.0 5.9 
 5.9 5.9 7.7 
 
Chi-square test *p<0.001, **p<0.01, ***p<0.05 
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